Your browser doesn't support javascript.
loading
Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo.
Schade, U F; Burmeister, I; Engel, R; Reinke, M; Wolter, D T.
Afiliação
  • Schade UF; Forschungsinstitut Borstel, FRG.
Lymphokine Res ; 8(3): 245-50, 1989.
Article em En | MEDLINE | ID: mdl-2506396
ABSTRACT
The LPS induced synthesis of tumor necrosis factor in macrophage cultures, as determined in a fibroblast cytolysis assay was found to be effectively blocked by inhibitors of lipoxygenases. Likewise, the presence of tumor necrosis factor in serum of D-galactosamine sensitized mice after challenge with endotoxin was suppressed by the lipoxygenase inhibitors. Indomethacin, a blocker of cycclooxygenase was neither in vivo nor in vitro effective in the prevention of the endotoxin-induced synthesis of TNF. From LPS-treated macrophages we were able to isolate 13-hydroxylinoleic acid, a lipoxygenase product, which is significantly increased after LPS treatment of the cells, covalently bound to cellular constituents and may, therefore, be possibly involved in the formation of TNF.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Inibidores de Lipoxigenase Limite: Animals Idioma: En Ano de publicação: 1989 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Inibidores de Lipoxigenase Limite: Animals Idioma: En Ano de publicação: 1989 Tipo de documento: Article